Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Osimertinib As First-Line Treatment of <i>EGFR</i> Mutation–Positive Advanced Non–Small-Cell Lung Cancer
PaperCitations, authors & open-access status
Osimertinib As First-Line Treatment of <i>EGFR</i> Mutation–Positive Advanced Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 544 citations, 2017 year and closed oa status.
544
Citations
2017
Year
closed
OA Status